-
Gold Reimagines Vision: A Groundbreaking Discovery to Treat Blindness Without Surgery or Gene Editing
21 Apr 2025 23:51 GMT
… developed a novel technique that could revolutionize the treatment … of vision loss caused by retinal degeneration—using … shift in how we treat retinal degeneration."
Successful Trials in … systems approved by the FDA, this technique offers …
-
The Residency Report: Study provides new insights into USH2A target end points
01 May 2025 00:31 GMT
… USH2A)–related retinal degeneration.
USH2A-related retinal degeneration, although rare … ophthalmology clinical trial end points
… treat macular telangiectasia type 2 have concluded, and the treatment … News release. Neurotech Pharmaceuticals. November 2, 2022 …
-
A genetic link between schizophrenia and retinal thinning
30 Apr 2025 22:54 GMT
Regression analysis identified significant associations between the polygenic risk scores for schizophrenia, pathway-specific scores, and specific retinal layers,1 according to coauthors Finn Rabe, PhD, from the Department of Adult Psychiatry and …
-
Repurposing a blood pressure drug may prevent vision loss in inherited blinding diseases
15 Apr 2025 17:30 GMT
… drug reserpine, approved in 1955 for high blood pressure, might treat … drugs. The idea would be to use such options to treat … until more effective treatments are developed that can … The required dosage for treating retinal degeneration, however, would be …
-
Reserpine shows promise in treating retinitis pigmentosa in rat studies
15 Apr 2025 16:49 GMT
… drug reserpine, approved in 1955 for high blood pressure, might treat … drugs. The idea would be to use such options to treat … until more effective treatments are developed that can … The required dosage for treating retinal degeneration, however, would be …
-
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
08 Apr 2025 12:00 GMT
… trial in adult and pediatric patients with inherited retinal degeneration … no observed drug related adverse … (CMC). The FDA requested additional information … developing therapies to treat patients with inherited retinal diseases (IRDs) and other treatments …
-
Researchers develop eye drops that slow progressive vision loss in mice
24 Mar 2025 20:29 GMT
… loss in humans was recently developed by researchers at the … the study in Communications Medicine, developed eye drops that contain a … the 1-week period of treatment, mice retained up to 75% … murine and human models of retinal degeneration. Commun Med. 2025;5( …
-
Kiora Pharmaceuticals Reports 2024 Results; Retinal Disease Drug Development Pipeline Continues to Advance; Cash and Short-Term Investments Expected to Fund Operations into 2027
25 Mar 2025 18:42 GMT
… that we are developing to treat inflammatory retinal diseases. … or systemic anti-inflammatory drugs, both of which … retinal degeneration. KIO-104 is being developed for the treatment … Investors@kiorapharma.com
KIORA PHARMACEUTICALS, INC.
CONSOLIDATED BALANCE …
-
Scientists develop eye drops that slow vision loss in animals with inherited retinal diseases
25 Mar 2025 15:08 GMT
… tumor growth in tough-to-treat breast and ovarian cancers: Study … author Alexandra Bernardo-Colon, researchers developed two eye drop formulations containing … -invasive and accessible treatment to slow vision loss in people with retinal degeneration.
-
NIH researchers develop eye drops that slow vision loss in animals
21 Mar 2025 19:21 GMT
… , March 21, 2025
Treatment shows potential to slow the … murine and human models of retinal degeneration.” Mar 21, 2025, Comms … science programs to develop sight-saving treatments and address special … is investigating the causes, treatments, and cures for both …
About
© 1995-2025